Cargando…
Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls
BACKGROUND: Colorectal cancer (CRC) is often diagnosed at a late stage with concomitant poor prognosis. The hypersensitive analytical technique of proteomics can detect molecular changes before the tumor is palpable. The surface-enhanced laser desorption/ionization-time of flight-mass spectra (SELDI...
Autores principales: | Liu, Ming, Li, Chun-Feng, Chen, Hong-Sheng, Lin, Luo-Qiang, Zhang, Chun-Peng, Zhao, Jin-Lu, Liu, Yan, Zhang, Shu-Jun, Jin, Jun-Chao, Wang, Lei, Liu, Jia-Ren |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862023/ https://www.ncbi.nlm.nih.gov/pubmed/20334691 http://dx.doi.org/10.1186/1477-5956-8-16 |
Ejemplares similares
-
Fresh raspberry phytochemical extract inhibits hepatic lesion in a Wistar rat model
por: Liu, Yan, et al.
Publicado: (2010) -
Urinary Polyamine Biomarker Panels with Machine-Learning Differentiated Colorectal Cancers, Benign Disease, and Healthy Controls
por: Nakajima, Tetsushi, et al.
Publicado: (2018) -
Evaluation of the diagnostic value of serum-based proteomics for colorectal cancer
por: Wang, Hui-Juan, et al.
Publicado: (2022) -
Right- and left-sided colorectal cancers respond differently to cetuximab
por: Wang, Feng, et al.
Publicado: (2015) -
The Comparable Microenvironment Shared by Colorectal Adenoma and Carcinoma: An Evidence of Stromal Proteomics
por: Yan, Keqiang, et al.
Publicado: (2022)